After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IMMX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Immix Biopharma Inc is $298.78M. A total of 1.8 million shares were traded on the day, compared to an average of 883.10K shares.
In the most recent transaction, Rachman Ilya M bought 746 shares of IMMX for 6.67 per share on Dec 10 ’25. After the transaction, the CEO and Chairman now owns 1,141,683 company shares. In a previous transaction on Dec 10 ’25, Morris Gabriel S bought 770 shares at 6.58 per share. IMMX shares that CFO owns now total 291,429.
Among the insiders who bought shares, Rachman Ilya M acquired of 2,500 shares on Sep 17 ’25 at a per-share price of $2.02. This resulted in the CEO and Chairman holding 1,140,937 shares of IMMX after the transaction. In another insider transaction, Morris Gabriel S bought 2,600 shares at $1.97 per share on Sep 16 ’25. Company shares held by the CFO now total 290,659.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IMMX has a high of $7.73 and a low of $1.34.
As of this writing, IMMX has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.16 per share and a lower estimate of -$0.16. The company reported an EPS of -$0.15 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IMMX’s latest balance sheet shows that the firm has $17.64M in Cash & Short Term Investments as of fiscal 2021. There were $50.00k in debt and $202.04k in liabilities at the time. Its Book Value Per Share was $0.25, while its Total Shareholder’s Equity was $17.99M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMMX is Buy with a score of 4.00.
